Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/33280
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKuzminova, Nataliia-
dc.contributor.authorIvankova, Anastasiya-
dc.contributor.authorRomanova, Valentyna-
dc.contributor.authorKalitai, Volodymyr-
dc.contributor.authorKulchytska, Olena-
dc.contributor.authorKnyazkova, Iryna-
dc.date.accessioned2023-12-01T11:47:54Z-
dc.date.available2023-12-01T11:47:54Z-
dc.date.issued2023-
dc.identifier.citationApelin-13 сoncentration in patients with essential hypertension, extrasystole and obesity / N. V. Kuzminova, A. V. Ivankova, V. O. Romanova, V. V. Kalitai, O. M. Kulchytska, I. I. Knyazkova // Journal of Obesity and Chronic Diseases. – 2023. – Volume 7, Supplement 1: Proceeding of 7th International Obesity and Metabolic Disorders Research Conference (ORC – 2023). – Р. S13–S14.en_US
dc.identifier.urihttp://repo.knmu.edu.ua/handle/123456789/33280-
dc.description.abstractToday metabolic markers of cardiovascular risk are being actively studied. One of them is apelin-13. Objective: To assess the concentration of apelin-13 in patients with hypertension and extrasystole depending on obesity.en_US
dc.language.isoenen_US
dc.subjectapelin-13en_US
dc.subjectessential hypertensionen_US
dc.subjectextrasystoleen_US
dc.subjectobesityen_US
dc.subject2023аen_US
dc.titleApelin-13 сoncentration in patients with essential hypertension, extrasystole and obesity.en_US
dc.typeThesisen_US
Appears in Collections:Наукові праці. Кафедра клінічної фармакології та внутрішньої медицини

Files in This Item:
File Description SizeFormat 
jocd-s1-orc-13-14.pdf118,65 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.